TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia - Junk, S; Klein, N; Schreek, S; Zimmermann, M; Möricke, A; Bleckmann, K; Cario, G; Kratz, CP; Schrappe, M; Stanulla, M (Klinische Pädiatrie, 2016)